These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37188718)

  • 1. Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease.
    Merchant JP; Zhu K; Henrion MYR; Zaidi SSA; Lau B; Moein S; Alamprese ML; Pearse RV; Bennett DA; Ertekin-Taner N; Young-Pearse TL; Chang R
    Commun Biol; 2023 May; 6(1):503. PubMed ID: 37188718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.
    Muratore CR; Rice HC; Srikanth P; Callahan DG; Shin T; Benjamin LN; Walsh DM; Selkoe DJ; Young-Pearse TL
    Hum Mol Genet; 2014 Jul; 23(13):3523-36. PubMed ID: 24524897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
    Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
    Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein.
    Young JE; Fong LK; Frankowski H; Petsko GA; Small SA; Goldstein LSB
    Stem Cell Reports; 2018 Mar; 10(3):1046-1058. PubMed ID: 29503090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
    Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
    Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.
    van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB
    Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.
    Hu NW; Corbett GT; Moore S; Klyubin I; O'Malley TT; Walsh DM; Livesey FJ; Rowan MJ
    Cell Rep; 2018 May; 23(7):1932-1938. PubMed ID: 29768194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
    Rowland HA; Hooper NM; Kellett KAB
    Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
    Sahlgren Bendtsen KM; Hall VJ
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.
    Jones DT; Graff-Radford J; Lowe VJ; Wiste HJ; Gunter JL; Senjem ML; Botha H; Kantarci K; Boeve BF; Knopman DS; Petersen RC; Jack CR
    Cortex; 2017 Dec; 97():143-159. PubMed ID: 29102243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling amyloid beta and tau pathology in human cerebral organoids.
    Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
    Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice.
    Cusulin C; Wells I; Badillo S; Duran-Pacheco GC; Baumann K; Patsch C
    Mol Cell Neurosci; 2019 Oct; 100():103392. PubMed ID: 31381983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.
    Harasta AE; Ittner LM
    Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
    Foveau B; Correia AS; Hébert SS; Rainone S; Potvin O; Kergoat MJ; Belleville S; Duchesne S; LeBlanc AC;
    J Alzheimers Dis; 2019; 67(3):893-910. PubMed ID: 30689579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains.
    Klein HU; McCabe C; Gjoneska E; Sullivan SE; Kaskow BJ; Tang A; Smith RV; Xu J; Pfenning AR; Bernstein BE; Meissner A; Schneider JA; Mostafavi S; Tsai LH; Young-Pearse TL; Bennett DA; De Jager PL
    Nat Neurosci; 2019 Jan; 22(1):37-46. PubMed ID: 30559478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.
    Berry BJ; Smith AST; Long CJ; Martin CC; Hickman JJ
    ACS Chem Neurosci; 2018 Jul; 9(7):1693-1701. PubMed ID: 29746089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.